Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II DOI Creative Commons
Joana Silva, Rebeca Alvariño, Márcia Inês Goettert

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: Nov. 17, 2023

EDITORIAL article Front. Pharmacol., 17 November 2023Sec. Ethnopharmacology Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1329769

Language: Английский

Deep-Sea-Derived Isobisvertinol Targets TLR4 to Exhibit Neuroprotective Activity via Anti-Inflammatory and Ferroptosis-Inhibitory Effects DOI Creative Commons
Zihan Xu,

Ming‐Min Xie,

Chun‐Lan Xie

et al.

Marine Drugs, Journal Year: 2025, Volume and Issue: 23(1), P. 49 - 49

Published: Jan. 20, 2025

Neuroinflammation and neuronal cell death are leading causes of in the elderly underlie various neurodegenerative diseases. These diseases involve complex pathophysiological mechanisms, including inflammatory responses, oxidative stress, ferroptosis. Compounds derived from deep-sea fungi exhibit low toxicity potent neuroprotective effects, offering a promising source for drug development. In this study, we isolated 44 natural products deep-sea-derived identified isobisvertinol (17) as compound with anti-inflammatory ferroptosis-inhibiting effects. Using LPS-induced microglial inflammation RSL3-induced ferroptosis models, found that 17 targets TLR4 to provide neuroprotection. Molecular docking studies revealed inhibits activation by occupying hydrophobic pocket at TLR4-MD2 binding site. Additionally, suppresses TLR4, reducing p38 MAPK phosphorylation, decreasing lipid peroxidation modulating mitochondrial membrane potential. Metabolomic analysis showed rescues alterations multiple metabolic pathways induced RSL3 increases levels antioxidant metabolites, glutamine, glutamate, glutathione. summary, our results indicate neural cells reduce inhibit while regulating pathways, mainly GSH synthesis, effects prevent neurons.

Language: Английский

Citations

0

Natural products in neurodegenerative diseases: recent advances and future outlook DOI Creative Commons

Lutfun Nahar,

Rawiwan Charoensup,

Kulyash Kalieva

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: March 19, 2025

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s are on the rise pose significant challenges due to lack of effective treatments. This review critically examines neuroprotective effects various natural products derived from plants, marine organisms, fungi. Natural have long been used in traditional medicine gaining attention modern drug discovery for their unique properties. The explains how these can protect neurons by influencing key biological pathways involved neurodegeneration. It discusses mechanisms including antioxidant effects, anti-inflammatory actions, modulation cellular signalling, support mitochondrial function. A systematic literature search was conducted minimize bias ensure rigorous study selection. Preclinical studies using animal models cell cultures show that secondary metabolites like polyphenols, alkaloids, terpenoids significantly reduce neuronal damage. Some clinical trials shown promising results. However, bioavailability, standardization, dosage must be addressed translate findings into practice. also evaluates potential synergy combining with conventional treatments, offering a complementary therapeutic approach. represent avenue developing innovative treatments neurodegenerative diseases. highlights research gaps proposes future directions. Future should focus overcoming existing refining improve efficacy safety settings. application knowledge has enhance quality life individuals affected

Language: Английский

Citations

0

Marine-Based Bioactive Compounds in Healthcare and Wellness Industries DOI

Luis Fernando Flores,

Francisco Pardo, Carlos S. Osorio‐González

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0

Cytarabine prevents neuronal damage by enhancing AMPK to stimulate PINK1 / Parkin-involved mitophagy in Parkinson's disease model DOI
Lanxin Li, Yang Zhang,

Zhengqian Chen

et al.

European Journal of Pharmacology, Journal Year: 2024, Volume and Issue: 977, P. 176743 - 176743

Published: June 15, 2024

Language: Английский

Citations

3

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions DOI
Yingying Gu,

Xinru Zhao,

Nan Zhang

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 102, P. 102577 - 102577

Published: Nov. 10, 2024

Language: Английский

Citations

3

Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis DOI
Han Wang,

Yi-Ti Liu,

Yanling Ren

et al.

Journal of Neuroimmunology, Journal Year: 2024, Volume and Issue: 388, P. 578290 - 578290

Published: Jan. 13, 2024

Language: Английский

Citations

2

Effect of Selenium nanoparticles on Paraquat-induced-neuroinflammation and oligodendocyte modulation: Implication of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway DOI

Reda Abdelnasser Imam,

Fatma E. Hassan, Isra H. Ali

et al.

Tissue and Cell, Journal Year: 2024, Volume and Issue: 89, P. 102454 - 102454

Published: June 19, 2024

Language: Английский

Citations

2

Integrating Blood Biomarkers and Marine Brown Algae-Derived Inhibitors in Parkinson’s Disease: A Multi-scale Approach from Interactomics to Quantum Mechanics DOI

Jency Roshni,

S. Mahema,

Sheikh F. Ahmad

et al.

Molecular Biotechnology, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 3, 2024

Language: Английский

Citations

0

Bioengineering of Marine Metabolite-Based Nanotheranostics for Effective Alzheimer's Treatment DOI

Balaji Govindaswamy,

Murugappan Kumarappan,

Kevin Stephen

et al.

Advances in medical technologies and clinical practice book series, Journal Year: 2024, Volume and Issue: unknown, P. 235 - 264

Published: Aug. 30, 2024

Alzheimer's disease (AD) remains a significant healthcare issue, and novel treatment approaches are needed. Due to their structural variety pharmacological potential, marine metabolites excellent sources for drug development. In recent years, nanotheranostics, merger of therapeutic diagnostic functions inside nanoscale platforms, have received increased attention potential in precision medicine. This chapter will focus on the integration into these nanotheranostic systems, allowing early illness identification real-time monitoring responses. Finally, this book highlights promise bioengineering metabolite-based nanotheranostics as option disease. By leveraging synergistic interaction bioresources nanotechnology, new platforms show enormous addressing unmet needs patients, ultimately leading medicine paradigms neurodegenerative illnesses.

Language: Английский

Citations

0

Algal polysaccharides: new perspectives for the treatment of basal ganglia neurodegenerative diseases DOI Creative Commons

Anthony Pedro da Silva Lucena,

Eudes Euler de Souza Lucena,

Sebastião Pacheco Duque Neto

et al.

Frontiers in Neuroanatomy, Journal Year: 2024, Volume and Issue: 18

Published: Oct. 16, 2024

The objective of this review was to verify the therapeutic effect polysaccharides derived from algae in neurodegenerative disease models involving basal ganglia. To achieve goal, a literature search conducted PubMed, Science Direct, Scopus, Web Science, Embase, and Google Scholar databases. descriptors “neuroprotective or neural regenerative immunomodulatory activity neuroprotection,” “polysaccharide carbohydrate polymers,” “marine seaweed,” “basal ganglia” according Preferred Reporting Items for Systematic reviews Meta-Analyses (PRISMA) methodology were used. This involved steps searching, pre-selection, inclusion articles. A total 737 records identified. Following data analysis, 698 studies excluded, resulting final sample 8 studies. Species such as Turbinaria decurrens , Gracilaria cornea Chlorella pyrenoidosa Arthrospira (Spirulina) platensis Fucus vesiculosus Laminaria japonica have demonstrated significant neuroprotective effects. suggests that marine possess potential neuroprotection, modulation inflammation, amelioration functional deficits. Their use warrants further consideration.

Language: Английский

Citations

0